Ion Channel Innovations Report issue

For profit Phase 2
Founded: Ardsley NY United States (2000)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2007
NCT00495053
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

hmaxi-k (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erectile Dysfunction (Phase 2)

Urinary Bladder, Overactive (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1